| Literature DB >> 24169349 |
T Gathani1, R Ali2, A Balkwill2, J Green2, G Reeves2, V Beral2, K A Moser2.
Abstract
BACKGROUND: In the United Kingdom, breast cancer incidence is lower in South Asian and Black women than in White women, but the extent to which this is due to known risk factors is unknown. In a large prospective study, we describe breast cancer incidence by ethnicity, before and after adjustment for known risk factors for the disease.Entities:
Mesh:
Year: 2013 PMID: 24169349 PMCID: PMC3887283 DOI: 10.1038/bjc.2013.632
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Definitions of ethnicity used in the analysis
| South Asian | (a) Reported on the Million Women Study questionnaire that ethnic group was ‘South Asian', or (b) reported on the Million Women Study questionnaire that ethnic group was ‘Asian' and that they were not born in China, Hong Kong, Malaysia, Japan, the Philippines, Thailand, Burma, Singapore, Vietnam or Iran, or (c) ethnic group could not be determined from the Million Women Study (‘Other', not stated or missing) but recorded as being of Indian, Pakistani, or Bangladeshi ethnicity on one or more HES records |
| Black | (a) Reported on the Million Women Study questionnaire that ethnic group was ‘Black', or (b) ethnic group could not be determined from the Million Women Study but recorded as being of ‘Black' ethnicity on one or more HES records |
| White | (a) Reported on the Million Women Study questionnaire that ethnic group was ‘White', or (b) ethnic group could not be determined from the Million Women Study but recorded as White on all their HES records with stated ethnicity |
| Other | (a) ‘Other', not stated or missing ethnicity according to the Million Women Study and who could not be assigned to South Asian, Black, or White ethnic groups from HES records, or (b) reported on the Million Women Study questionnaire that ethnic group was ‘Asian' and that they were born in China, Hong Kong, Malaysia, Japan, the Philippines, Thailand, Burma, Singapore, Vietnam, or Iran (i.e., not South Asian), or (c) inconsistent recording of ethnicity |
Abbreviation: HES=Hospital Episode Statistics.
The largest specific ethnic group included under ‘Other' was Chinese women, defined as: (a) reported on the Million Women Study questionnaire that ethnic group was ‘Asian' and that they were born in China, Hong Kong, Malaysia or Singapore, or (b) ethnic group could not be determined from the Million Women Study but recorded as being of ‘Chinese' ethnicity on one or more HES records.
Characteristics at recruitment of South Asian, Black, and White women in England, and details of follow-up
| | |||
| Number of women | 5877 | 4919 | 1 038 144 |
| % ( | 64 (3765) | 69 (3385) | 33 (338 392) |
| Age at menarche (years), mean (s.d.) | 13.7 (1.6) | 13.6 (1.8) | 13.0 (1.6) |
| Number of children (all women), mean (s.d.) | 2.7 (1.6) | 2.9 (1.8) | 2.1 (1.2) |
| Age (years) at first birth (parous women), mean (s.d.) | 23.8 (4.9) | 22.2 (4.7) | 23.8 (4.3) |
| % ( | 85 (3050) | 83 (2486) | 69 (506 547) |
| Body mass index (kg m−2), mean (s.d.) | 26.3 (4.6) | 28.1 (5.2) | 26.2 (4.7) |
| Height (cm), mean (s.d.) | 157.7 (6.7) | 161.8 (7.1) | 162.1 (6.7) |
| % ( | 75 (4266) | 38 (1829) | 23 (240 220) |
| % ( | 22 (1261) | 29 (1350) | 35 (355 731) |
| % ( | 5 (312) | 7 (340) | 10 (98 709) |
| Women years of follow-up (1000 s) | 69.9 | 56.3 | 12 127.4 |
| Number of incident breast cancers | 217 | 180 | 45 191 |
*P<0.001 for each comparison.
Relative risk (RR) for breast cancer in South Asian and Black compared with White women in England, adjusted by various factors
| Number of incident breast cancers | South Asian women: 217 | Black women: 180 |
| Deprivation | 0.83 (0.72–0.95) | 0.86 (0.74–0.99) |
| Age at menarche | 0.83 (0.72–0.94) | 0.85 (0.74–0.99) |
| Childbearing and breastfeeding history | 0.84 (0.74–0.96) | 0.88 (0.76–1.02) |
| Body mass index | 0.82 (0.72–0.94) | 0.84 (0.72–0.97) |
| Height | 0.86 (0.75–0.98) | 0.85 (0.74–0.99) |
| Alcohol consumption | 0.86 (0.75–0.99) | 0.87 (0.75–1.01) |
| Use of menopausal hormone therapy | 0.85 (0.75–0.98) | 0.87 (0.75–1.00) |
| First-degree relative with breast cancer | 0.84 (0.73–0.96) | 0.86 (0.74–0.99) |